225 related articles for article (PubMed ID: 31668126)
1. Effect of promoter, promoter mutation and enhancer on transgene expression mediated by episomal vectors in transfected HEK293, Chang liver and primary cells.
Xu ZJ; Jia YL; Wang M; Yi DD; Zhang WL; Wang XY; Zhang JH
Bioengineered; 2019 Dec; 10(1):548-560. PubMed ID: 31668126
[TBL] [Abstract][Full Text] [Related]
2. The EF-1α promoter maintains high-level transgene expression from episomal vectors in transfected CHO-K1 cells.
Wang X; Xu Z; Tian Z; Zhang X; Xu D; Li Q; Zhang J; Wang T
J Cell Mol Med; 2017 Nov; 21(11):3044-3054. PubMed ID: 28557288
[TBL] [Abstract][Full Text] [Related]
3. Generation of a tumor- and tissue-specific episomal non-viral vector system.
Haase R; Magnusson T; Su B; Kopp F; Wagner E; Lipps H; Baiker A; Ogris M
BMC Biotechnol; 2013 Jun; 13():49. PubMed ID: 23734827
[TBL] [Abstract][Full Text] [Related]
4. Sustained, high transgene expression in liver with plasmid vectors using optimized promoter-enhancer combinations.
Magnusson T; Haase R; Schleef M; Wagner E; Ogris M
J Gene Med; 2011 Jul; 13(7-8):382-91. PubMed ID: 21721074
[TBL] [Abstract][Full Text] [Related]
5. Construction of a new minicircle DNA carrying an enhanced green florescent protein reporter gene for efficient expression into mammalian cell lines.
Sanei Ata-Abadi N; Dormiani K; Khazaie Y; Ghaedi K; Forouzanfar M; Lachinani L; Rezaei N; Kiani-Esfahani A; Nasr-Esfahani MH
Mol Biol Rep; 2015 Jul; 42(7):1175-85. PubMed ID: 25736052
[TBL] [Abstract][Full Text] [Related]
6. Cell Compatibility of an Eposimal Vector Mediated by the Characteristic Motifs of Matrix Attachment Regions.
Wang TY; Wang L; Yang YX; Zhao CP; Jia YL; Li Q; Zhang JH; Peng YY; Wang M; Xu HY; Wang XY
Curr Gene Ther; 2016; 16(4):271-277. PubMed ID: 27915978
[TBL] [Abstract][Full Text] [Related]
7. Enhancing expression level and stability of transgene mediated by episomal vector via buffering DNA methyltransferase in transfected CHO cells.
Wang XY; Yi DD; Wang TY; Wu YF; Chai YR; Xu DH; Zhao CP; Song C
J Cell Biochem; 2019 Sep; 120(9):15661-15670. PubMed ID: 31074065
[TBL] [Abstract][Full Text] [Related]
8. Enhanced transgene expression using cis-acting elements combined with the EF1 promoter in a mammalian expression system.
Wang W; Guo X; Li YM; Wang XY; Yang XJ; Wang YF; Wang TY
Eur J Pharm Sci; 2018 Oct; 123():539-545. PubMed ID: 30110655
[TBL] [Abstract][Full Text] [Related]
9. Combination of MAR and intron increase transgene expression of episomal vectors in CHO cells.
Wang XY; Zhang WL; Zhang X; Fu YS; Wang HM; Sun QL; Li Q; Jia YL; Zhang JH; Wang TY
Biotechnol J; 2023 Dec; 18(12):e2200643. PubMed ID: 37551822
[TBL] [Abstract][Full Text] [Related]
10. Hepatocyte-specific gene expression from integrated lentiviral vectors.
Nash KL; Jamil B; Maguire AJ; Alexander GJ; Lever AM
J Gene Med; 2004 Sep; 6(9):974-83. PubMed ID: 15352070
[TBL] [Abstract][Full Text] [Related]
11. Non-integrating lentiviral vectors based on the minimal S/MAR sequence retain transgene expression in dividing cells.
Xu Z; Chen F; Zhang L; Lu J; Xu P; Liu G; Xie X; Mu W; Wang Y; Liu D
Sci China Life Sci; 2016 Oct; 59(10):1024-1033. PubMed ID: 27614752
[TBL] [Abstract][Full Text] [Related]
12. Expression of a transgene encoded on a non-viral episomal vector is not subject to epigenetic silencing by cytosine methylation.
Jenke AC; Scinteie MF; Stehle IM; Lipps HJ
Mol Biol Rep; 2004 Jun; 31(2):85-90. PubMed ID: 15293783
[TBL] [Abstract][Full Text] [Related]
13. The β-globin Replicator greatly enhances the potential of S/MAR based episomal vectors for gene transfer into human haematopoietic progenitor cells.
Stavrou EF; Lazaris VM; Giannakopoulos A; Papapetrou E; Spyridonidis A; Zoumbos NC; Gkountis A; Athanassiadou A
Sci Rep; 2017 Jan; 7():40673. PubMed ID: 28106085
[TBL] [Abstract][Full Text] [Related]
14. Functional promoter testing using a modified lentiviral transfer vector.
Geller SF; Ge PS; Visel M; Greenberg KP; Flannery JG
Mol Vis; 2007 May; 13():730-9. PubMed ID: 17563724
[TBL] [Abstract][Full Text] [Related]
15. Lentiviral Vectors Mediate Long-Term and High Efficiency Transgene Expression in HEK 293T cells.
Mao Y; Yan R; Li A; Zhang Y; Li J; Du H; Chen B; Wei W; Zhang Y; Sumners C; Zheng H; Li H
Int J Med Sci; 2015; 12(5):407-15. PubMed ID: 26005375
[TBL] [Abstract][Full Text] [Related]
16. Persistent episomal transgene expression in liver following delivery of a scaffold/matrix attachment region containing non-viral vector.
Argyros O; Wong SP; Niceta M; Waddington SN; Howe SJ; Coutelle C; Miller AD; Harbottle RP
Gene Ther; 2008 Dec; 15(24):1593-605. PubMed ID: 18633447
[TBL] [Abstract][Full Text] [Related]
17. Long-term transgene expression can be mediated in the brain by adenoviral vectors when powerful neuron-specific promoters are used.
Glover CP; Bienemann AS; Hopton M; Harding TC; Kew JN; Uney JB
J Gene Med; 2003 Jul; 5(7):554-9. PubMed ID: 12825194
[TBL] [Abstract][Full Text] [Related]
18. The herpesvirus saimiri ORF 73 regulatory region provides long-term transgene expression in human carcinoma cell lines.
Giles MS; Smith PG; Coletta PL; Hall KT; Whitehouse A
Cancer Gene Ther; 2003 Jan; 10(1):49-56. PubMed ID: 12489028
[TBL] [Abstract][Full Text] [Related]
19. Modified S/MAR episomal vectors for stably expressing fluorescent protein-tagged transgenes with small cell-to-cell fluctuations.
Mizutani A; Kikkawa E; Matsuno A; Shigenari A; Okinaga H; Murakami M; Ishida H; Tanaka M; Inoko H
Anal Biochem; 2013 Dec; 443(1):113-6. PubMed ID: 23969013
[TBL] [Abstract][Full Text] [Related]
20. Developing extrachromosomal gene expression vector technologies: an overview.
Wade-Martins R
Methods Mol Biol; 2011; 738():1-17. PubMed ID: 21431716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
